GI & Endoscopy

The FDA approved Gilead Sciences' Vosevi as a second line therapy for chronic hepatitis C.

The colorectal cancer treatment market could reach $5.03 billion by 2021, growing at a compound annual growth rate of 2.21 percent from 2016 to 2021, according to Market Data Forecast analysis.

Five years ago, Michael DiMarino, MD, of Woodbury, N.J.-based DiMarino-Kroop-Prieto Gastrointestinal Associates, began using gMed's products to assist with the value process. He reported he has never experienced such a simplified, user-friendly platform.

Paul Craig, MD, is a gastroenterologist at Spokane, Wash.-based Valley Gastroenterology.

The Spokane (Wash.) Digestive Disease Center has been serving residents of Spokane since 1993.

The American Association of Physicians of Indian Origin named Iyunni Venkata Nath, MD, its Most Distinguished Physician of the Year for 2017 at its annual convention, TBN Weekly reports.

RedHill Biopharma announced all enrolled patients completed treatment for the phase II study of its irritable bowel syndrome with diarrhea drug.

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of July 10 to July 14.

The American Cancer Society awarded five community health centers $100,000 in grants to increase colorectal cancer screenings in American Indian and Alaska Native populations.

VMG Health completed a regional analysis of case volume per specialty as a percent of total cases at multispecialty ASCs through its VMG Health's Multi-Specialty ASC Intellimarker 2017.